The miR-30 family: Versatile players in breast cancer
The microRNA family, miR-30, plays diverse roles in regulating key aspects of neoplastic transformation, metastasis, and clinical outcomes in different types of tumors. Accumulating evidence proves that miR-30 family is pivotal in the breast cancer development by controlling critical signaling pathw...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-03-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317692204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849687207115227136 |
|---|---|
| author | Su-Jin Yang Su-Yu Yang Dan-Dan Wang Xiu Chen Hong-Yu Shen Xiao-Hui Zhang Shan-Liang Zhong Jin-Hai Tang Jian-Hua Zhao |
| author_facet | Su-Jin Yang Su-Yu Yang Dan-Dan Wang Xiu Chen Hong-Yu Shen Xiao-Hui Zhang Shan-Liang Zhong Jin-Hai Tang Jian-Hua Zhao |
| author_sort | Su-Jin Yang |
| collection | DOAJ |
| description | The microRNA family, miR-30, plays diverse roles in regulating key aspects of neoplastic transformation, metastasis, and clinical outcomes in different types of tumors. Accumulating evidence proves that miR-30 family is pivotal in the breast cancer development by controlling critical signaling pathways and relevant oncogenes. Here, we review the roles of miR-30 family members in the tumorigenesis, metastasis, and drug resistance of breast cancer, and their application to predict the prognosis of breast cancer patients. We think miR-30 family members would be promising biomarkers for breast cancer and may bring a novel insight in molecular targeted therapy of breast cancer. |
| format | Article |
| id | doaj-art-fb6ee521d6d348209cee9c6ff28495c7 |
| institution | DOAJ |
| issn | 1423-0380 |
| language | English |
| publishDate | 2017-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Tumor Biology |
| spelling | doaj-art-fb6ee521d6d348209cee9c6ff28495c72025-08-20T03:22:22ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317692204The miR-30 family: Versatile players in breast cancerSu-Jin Yang0Su-Yu Yang1Dan-Dan Wang2Xiu Chen3Hong-Yu Shen4Xiao-Hui Zhang5Shan-Liang Zhong6Jin-Hai Tang7Jian-Hua Zhao8Department of General Surgery, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaNanjing University of Chinese Medicine, Nanjing, ChinaDepartment of General Surgery, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaDepartment of General Surgery, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaDepartment of General Surgery, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaCenter of Clinical Laboratory, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaCenter of Clinical Laboratory, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaDepartment of General Surgery, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaCenter of Clinical Laboratory, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province, Nanjing, ChinaThe microRNA family, miR-30, plays diverse roles in regulating key aspects of neoplastic transformation, metastasis, and clinical outcomes in different types of tumors. Accumulating evidence proves that miR-30 family is pivotal in the breast cancer development by controlling critical signaling pathways and relevant oncogenes. Here, we review the roles of miR-30 family members in the tumorigenesis, metastasis, and drug resistance of breast cancer, and their application to predict the prognosis of breast cancer patients. We think miR-30 family members would be promising biomarkers for breast cancer and may bring a novel insight in molecular targeted therapy of breast cancer.https://doi.org/10.1177/1010428317692204 |
| spellingShingle | Su-Jin Yang Su-Yu Yang Dan-Dan Wang Xiu Chen Hong-Yu Shen Xiao-Hui Zhang Shan-Liang Zhong Jin-Hai Tang Jian-Hua Zhao The miR-30 family: Versatile players in breast cancer Tumor Biology |
| title | The miR-30 family: Versatile players in breast cancer |
| title_full | The miR-30 family: Versatile players in breast cancer |
| title_fullStr | The miR-30 family: Versatile players in breast cancer |
| title_full_unstemmed | The miR-30 family: Versatile players in breast cancer |
| title_short | The miR-30 family: Versatile players in breast cancer |
| title_sort | mir 30 family versatile players in breast cancer |
| url | https://doi.org/10.1177/1010428317692204 |
| work_keys_str_mv | AT sujinyang themir30familyversatileplayersinbreastcancer AT suyuyang themir30familyversatileplayersinbreastcancer AT dandanwang themir30familyversatileplayersinbreastcancer AT xiuchen themir30familyversatileplayersinbreastcancer AT hongyushen themir30familyversatileplayersinbreastcancer AT xiaohuizhang themir30familyversatileplayersinbreastcancer AT shanliangzhong themir30familyversatileplayersinbreastcancer AT jinhaitang themir30familyversatileplayersinbreastcancer AT jianhuazhao themir30familyversatileplayersinbreastcancer AT sujinyang mir30familyversatileplayersinbreastcancer AT suyuyang mir30familyversatileplayersinbreastcancer AT dandanwang mir30familyversatileplayersinbreastcancer AT xiuchen mir30familyversatileplayersinbreastcancer AT hongyushen mir30familyversatileplayersinbreastcancer AT xiaohuizhang mir30familyversatileplayersinbreastcancer AT shanliangzhong mir30familyversatileplayersinbreastcancer AT jinhaitang mir30familyversatileplayersinbreastcancer AT jianhuazhao mir30familyversatileplayersinbreastcancer |